This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| unigram | frequency |
|---|---|
| patients | 262046 |
| covid | 82219 |
| study | 64984 |
| disease | 58299 |
| patient | 55779 |
| clinical | 55060 |
| treatment | 53973 |
| may | 48632 |
| results | 45085 |
| infection | 40662 |
| care | 39833 |
| risk | 39192 |
| cells | 37917 |
| blood | 37172 |
| associated | 36501 |
| also | 35958 |
| group | 35579 |
| cases | 35284 |
| data | 34741 |
| severe | 34611 |
| acute | 32412 |
| cell | 31971 |
| respiratory | 31897 |
| one | 31644 |
| using | 31586 |
| high | 31043 |
| time | 30558 |
| use | 29665 |
| used | 29163 |
| therapy | 29037 |
| hospital | 28913 |
| sars | 28020 |
| two | 27196 |
| analysis | 26927 |
| years | 26317 |
| days | 25748 |
| age | 25063 |
| studies | 24811 |
| cov | 24177 |
| health | 23599 |
| mortality | 23420 |
| however | 23094 |
| methods | 22810 |
| performed | 22452 |
| increased | 22387 |
| non | 21974 |
| compared | 21635 |
| based | 21601 |
| significant | 21589 |
| levels | 21499 |
| diagnosis | 21426 |
| case | 21292 |
| coronavirus | 20946 |
| will | 20806 |
| syndrome | 20634 |
| lung | 20287 |
| higher | 19977 |
| pneumonia | 19879 |
| cancer | 19817 |
| day | 19775 |
| first | 19691 |
| reported | 19602 |
| due | 19542 |
| cd | 19537 |
| positive | 19468 |
| control | 19308 |
| symptoms | 19214 |
| including | 19068 |
| medical | 18762 |
| found | 18723 |
| well | 18663 |
| i | 18439 |
| showed | 17865 |
| rate | 17819 |
| icu | 17755 |
| management | 17675 |
| system | 17523 |
| related | 17387 |
| without | 17118 |
| infections | 16969 |
| children | 16915 |
| response | 16864 |
| mean | 16741 |
| early | 16501 |
| pulmonary | 16418 |
| virus | 16335 |
| il | 16310 |
| low | 16281 |
| factors | 16174 |
| mg | 16040 |
| among | 15960 |
| different | 15931 |
| number | 15879 |
| significantly | 15802 |
| surgery | 15494 |
| failure | 15441 |
| groups | 15251 |
| viral | 15065 |
| vs | 15031 |
| chronic | 15006 |
| months | 14919 |
| new | 14919 |
| ct | 14835 |
| within | 14827 |
| test | 14704 |
| specific | 14593 |
| human | 14412 |
| included | 14331 |
| common | 14273 |
| treated | 14201 |
| level | 14107 |
| conclusion | 14105 |
| following | 14096 |
| expression | 14042 |
| anti | 13893 |
| outcomes | 13880 |
| normal | 13769 |
| liver | 13737 |
| present | 13681 |
| three | 13670 |
| total | 13639 |
| review | 13624 |
| ml | 13613 |
| type | 13564 |
| dose | 13430 |
| observed | 13421 |
| effect | 13404 |
| pandemic | 13383 |
| injury | 13276 |
| findings | 13268 |
| important | 13247 |
| function | 13219 |
| potential | 13211 |
| effects | 13192 |
| median | 13089 |
| year | 12937 |
| increase | 12827 |
| lower | 12783 |
| role | 12774 |
| negative | 12684 |
| immune | 12659 |
| outcome | 12597 |
| complications | 12337 |
| protein | 12296 |
| evidence | 12229 |
| primary | 12086 |
| period | 12081 |
| respectively | 12067 |
| diseases | 11979 |
| surgical | 11943 |
| inflammatory | 11718 |
| population | 11692 |
| renal | 11627 |
| imaging | 11622 |
| received | 11576 |
| although | 11568 |
| post | 11551 |
| available | 11458 |
| cardiac | 11415 |
| activity | 11353 |
| admission | 11335 |
| drug | 11251 |
| range | 11081 |
| novel | 10974 |
| identified | 10917 |
| follow | 10873 |
| changes | 10758 |
| serum | 10755 |
| considered | 10727 |
| possible | 10657 |
| table | 10591 |
| method | 10512 |
| cause | 10475 |
| pressure | 10464 |
| report | 10457 |
| need | 10426 |
| samples | 10369 |
| survival | 10367 |
| incidence | 10352 |
| many | 10350 |
| plasma | 10261 |
| developed | 10253 |
| ventilation | 10172 |
| less | 10132 |
| tissue | 10085 |
| score | 10060 |
| trial | 10052 |
| factor | 10025 |
| development | 9738 |
| information | 9727 |
| several | 9710 |
| shown | 9660 |
| characteristics | 9645 |
| conclusions | 9639 |
| support | 9611 |
| model | 9586 |
| transplantation | 9537 |
| multiple | 9462 |
| infected | 9449 |
| presence | 9448 |
| single | 9448 |
| long | 9385 |
| kg | 9382 |
| intensive | 9303 |
| similar | 9299 |
| according | 9269 |
| death | 9194 |
| research | 9174 |
| influenza | 9132 |
| heart | 9127 |
| standard | 9126 |
| severity | 9126 |
| small | 9109 |
| addition | 9102 |
| testing | 9075 |
| cohort | 9069 |
| induced | 9010 |
| reduced | 8991 |
| china | 8856 |
| diagnostic | 8852 |
| evaluation | 8842 |
| quality | 8773 |
| critical | 8771 |
| emergency | 8752 |
| large | 8652 |
| therefore | 8652 |
| laboratory | 8610 |
| impact | 8598 |
| guidelines | 8598 |
| background | 8581 |
| often | 8540 |
| effective | 8537 |
| pcr | 8496 |
| required | 8473 |
| unit | 8439 |
| criteria | 8406 |
| term | 8348 |
| confirmed | 8337 |
| pain | 8330 |
| initial | 8323 |
| ill | 8307 |
| life | 8244 |
| given | 8232 |
| assessment | 8220 |
| major | 8187 |
| current | 8152 |
| transplant | 8147 |
| chest | 8140 |
| sepsis | 8137 |
| gene | 8131 |
| include | 8131 |
| even | 8110 |
| history | 8103 |
| rates | 8082 |
| obtained | 8073 |
| safety | 8066 |
| per | 8061 |
| aim | 8059 |
| therapeutic | 8057 |
| status | 8045 |
| hours | 8043 |
| ci | 7992 |
| association | 7937 |
| general | 7894 |
| decreased | 7866 |
| authors | 7842 |
| transfusion | 7814 |
| approach | 7775 |
| ii | 7770 |
| retrospective | 7744 |
| cord | 7713 |
| overall | 7712 |
| known | 7706 |
| tumor | 7695 |
| drugs | 7687 |
| presented | 7679 |
| asthma | 7678 |
| features | 7669 |
| brain | 7647 |
| evaluated | 7645 |
| old | 7641 |
| center | 7634 |
| phase | 7631 |
| introduction | 7620 |
| detected | 7587 |
| administration | 7585 |
| differences | 7579 |
| admitted | 7572 |
| weeks | 7568 |
| four | 7553 |
| fever | 7550 |
| practice | 7520 |
| tests | 7512 |
| difference | 7507 |
| procedures | 7497 |
| result | 7488 |
| onset | 7469 |
| oxygen | 7465 |
| healthcare | 7453 |
| value | 7444 |
| volume | 7407 |
| course | 7384 |
| like | 7363 |
| since | 7350 |
| detection | 7335 |
| provide | 7284 |
| lesions | 7270 |
| prior | 7254 |
| conditions | 7253 |
| followed | 7247 |
| diabetes | 7230 |
| pre | 7218 |
| transmission | 7148 |
| recent | 7144 |
| demonstrated | 7141 |
| th | 7120 |
| procedure | 7098 |
| antibodies | 7037 |
| measured | 7029 |
| infectious | 7012 |
| mm | 7009 |
| receptor | 7007 |
| critically | 7006 |
| described | 7002 |
| collected | 6996 |
| limited | 6979 |
| bacterial | 6971 |
| prevalence | 6965 |
| likely | 6961 |
| whether | 6960 |
| efficacy | 6948 |
| inflammation | 6941 |
| seen | 6910 |
| body | 6896 |
| especially | 6896 |
| flow | 6886 |
| exposure | 6852 |
| oral | 6841 |
| either | 6815 |
| monitoring | 6797 |
| defined | 6786 |
| donor | 6786 |
| adults | 6783 |
| might | 6756 |
| hospitalized | 6734 |
| second | 6717 |
| reduction | 6708 |
| subjects | 6687 |
| values | 6664 |
| experience | 6654 |
| caused | 6645 |
| invasive | 6639 |
| systemic | 6613 |
| randomized | 6604 |
| determine | 6585 |
| revealed | 6575 |
| reduce | 6574 |
| organ | 6552 |
| bone | 6539 |
| must | 6536 |
| antibody | 6527 |
| pediatric | 6520 |
| process | 6513 |
| adult | 6508 |
| key | 6508 |
| min | 6505 |
| secondary | 6492 |
| university | 6474 |
| events | 6425 |
| trials | 6419 |
| kidney | 6418 |
| duration | 6413 |
| activation | 6408 |
| community | 6400 |
| male | 6386 |
| donors | 6376 |
| illness | 6372 |
| diagnosed | 6363 |
| least | 6347 |
| evaluate | 6342 |
| department | 6342 |
| agents | 6321 |
| parameters | 6300 |
| mechanical | 6296 |
| examination | 6294 |
| ratio | 6289 |
| trauma | 6268 |
| order | 6249 |
| mice | 6237 |
| work | 6221 |
| previous | 6219 |
| staff | 6216 |
| resistance | 6206 |
| assessed | 6202 |
| additional | 6189 |
| versus | 6187 |
| platelet | 6177 |
| mild | 6153 |
| adverse | 6152 |
| loss | 6134 |
| underwent | 6105 |
| improve | 6076 |
| still | 6074 |
| suggest | 6063 |
| combination | 6034 |
| made | 6023 |
| screening | 6014 |
| measures | 6009 |
| elevated | 5993 |
| outbreak | 5959 |
| prevention | 5956 |
| stage | 5946 |
| dysfunction | 5944 |
| national | 5936 |
| ards | 5927 |
| needed | 5926 |
| poor | 5914 |
| medicine | 5900 |
| appropriate | 5897 |
| end | 5886 |
| women | 5863 |
| identify | 5862 |
| assess | 5859 |
| mri | 5853 |
| improvement | 5852 |
| fluid | 5850 |
| daily | 5849 |
| improved | 5838 |
| vascular | 5828 |
| healthy | 5824 |
| better | 5823 |
| us | 5815 |
| shock | 5811 |
| prospective | 5809 |
| right | 5805 |
| stay | 5797 |
| skin | 5786 |
| despite | 5774 |
| analyzed | 5769 |
| contrast | 5760 |
| stem | 5758 |
| objective | 5754 |
| date | 5752 |
| airway | 5734 |
| controlled | 5727 |
| cardiovascular | 5672 |
| decrease | 5657 |
| correlation | 5635 |
| left | 5635 |
| baseline | 5631 |
| rapid | 5619 |
| peripheral | 5607 |
| cytokine | 5607 |
| hypertension | 5606 |
| production | 5563 |
| intervention | 5559 |
| protocol | 5540 |
| tested | 5533 |
| determined | 5532 |
| change | 5531 |
| individuals | 5487 |
| five | 5483 |
| regarding | 5478 |
| various | 5466 |
| recommended | 5466 |
| hospitals | 5460 |
| setting | 5429 |
| wuhan | 5427 |
| co | 5414 |
| sample | 5412 |
| via | 5400 |
| acid | 5383 |
| main | 5359 |
| suspected | 5356 |
| average | 5354 |
| tract | 5337 |
| family | 5336 |
| hsct | 5327 |
| area | 5326 |
| weight | 5309 |
| another | 5282 |
| studied | 5275 |
| previously | 5269 |
| greater | 5269 |
| stroke | 5255 |
| controls | 5253 |
| involved | 5222 |
| dna | 5221 |
| ed | 5218 |
| increasing | 5218 |
| usually | 5213 |
| physical | 5212 |
| show | 5207 |
| molecular | 5191 |
| damage | 5190 |
| part | 5183 |
| older | 5168 |
| grade | 5168 |
| conducted | 5163 |
| size | 5156 |
| index | 5126 |
| units | 5125 |
| times | 5109 |
| local | 5108 |
| antibiotic | 5107 |
| acquired | 5096 |
| frequency | 5095 |
| active | 5095 |
| ace | 5079 |
| necessary | 5076 |
| pts | 5068 |
| complete | 5060 |
| recommendations | 5058 |
| signs | 5043 |
| functional | 5037 |
| good | 4994 |
| reports | 4986 |
| causes | 4983 |
| sensitivity | 4953 |
| series | 4947 |
| biopsy | 4937 |
| contact | 4922 |
| free | 4916 |
| presentation | 4904 |
| hiv | 4904 |
| disorders | 4900 |
| affected | 4896 |
| responses | 4887 |
| isolated | 4849 |
| systems | 4839 |
| receiving | 4839 |
| state | 4838 |
| home | 4837 |
| female | 4808 |
| prognosis | 4806 |
| objectives | 4806 |
| literature | 4799 |
| direct | 4798 |
| moderate | 4793 |
| arterial | 4790 |
| distress | 4779 |
| progression | 4779 |
| provided | 4766 |
| currently | 4765 |
| areas | 4759 |
| lead | 4758 |
| hepatitis | 4728 |
| involvement | 4718 |
| short | 4710 |
| recently | 4703 |
| central | 4699 |
| particularly | 4694 |
| recovery | 4692 |
| people | 4692 |
| frequent | 4691 |
| systematic | 4682 |
| prevent | 4678 |
| develop | 4672 |
| abdominal | 4660 |
| mechanisms | 4653 |
| died | 4649 |
| rna | 4646 |
| postoperative | 4643 |
| technique | 4624 |
| intravenous | 4624 |
| antibiotics | 4592 |
| chemotherapy | 4591 |
| six | 4588 |
| room | 4588 |
| line | 4587 |
| rare | 4582 |
| length | 4561 |
| comparison | 4558 |
| count | 4551 |
| benefit | 4525 |
| highly | 4522 |
| muscle | 4522 |
| resistant | 4516 |
| world | 4513 |
| remains | 4508 |
| venous | 4495 |
| access | 4490 |
| help | 4481 |
| occur | 4479 |
| gvhd | 4475 |
| genes | 4473 |
| lack | 4472 |
| variables | 4471 |
| frequently | 4471 |
| services | 4470 |
| team | 4468 |
| culture | 4466 |
| host | 4463 |
| training | 4455 |
| occurred | 4446 |
| hospitalization | 4445 |
| proteins | 4433 |
| iv | 4417 |
| bleeding | 4402 |
| igg | 4401 |
| international | 4386 |
| countries | 4372 |
| published | 4366 |
| discharge | 4362 |
| strategies | 4362 |
| septic | 4357 |
| complex | 4344 |
| myocardial | 4331 |
| interest | 4322 |
| individual | 4316 |
| useful | 4312 |
| week | 4303 |
| vitro | 4300 |
| form | 4280 |
| month | 4268 |
| antigen | 4255 |
| graft | 4248 |
| knowledge | 4241 |
| physicians | 4240 |
| cm | 4235 |
| purpose | 4235 |
| hand | 4230 |
| fibrosis | 4229 |
| underlying | 4228 |
| public | 4226 |
| require | 4223 |
| design | 4215 |
| neurological | 4208 |
| cytokines | 4205 |
| requiring | 4203 |
| routine | 4199 |
| future | 4199 |
| administered | 4181 |
| viruses | 4180 |
| condition | 4180 |
| growth | 4173 |
| models | 4173 |
| investigated | 4172 |
| established | 4158 |
| concentration | 4156 |
| point | 4156 |
| en | 4149 |
| best | 4146 |
| mass | 4145 |
| assay | 4119 |
| independent | 4118 |
| furthermore | 4116 |
| doi | 4114 |
| air | 4110 |
| clinically | 4103 |
| fi | 4098 |
| der | 4093 |
| whereas | 4077 |
| morbidity | 4061 |
| target | 4058 |
| later | 4054 |
| absence | 4037 |
| scores | 4037 |
| every | 4035 |
| manifestations | 4033 |
| artery | 4023 |
| mutations | 4020 |
| genetic | 4003 |
| site | 3997 |
| whole | 3979 |
| isolation | 3977 |
| combined | 3976 |
| markers | 3976 |
| states | 3973 |
| leading | 3971 |
| concentrations | 3968 |
| taken | 3958 |
| dependent | 3954 |
| distribution | 3946 |
| recipients | 3939 |
| pattern | 3932 |
| side | 3932 |
| spread | 3919 |
| doses | 3918 |
| suggested | 3909 |
| surface | 3906 |
| able | 3902 |
| cough | 3901 |
| treatments | 3897 |
| analyses | 3896 |
| scale | 3896 |
| last | 3895 |
| types | 3881 |
| therapies | 3876 |
| commonly | 3872 |
| open | 3868 |
| majority | 3866 |
| reviewed | 3860 |
| stress | 3860 |
| copd | 3859 |
| decision | 3857 |
| id | 3857 |
| reaction | 3853 |
| abnormalities | 3849 |
| marrow | 3849 |
| safe | 3848 |
| hepatic | 3844 |
| program | 3832 |
| breast | 3828 |
| mediated | 3824 |
| bacteria | 3822 |
| regression | 3818 |
| elderly | 3816 |
| self | 3816 |
| relationship | 3814 |
| journal | 3798 |
| membrane | 3797 |
| mechanism | 3792 |
| release | 3791 |
| upper | 3787 |
| indicated | 3785 |
| comorbidities | 3781 |
| tumors | 3774 |
| participants | 3772 |
| statistical | 3771 |
| society | 3768 |
| images | 3765 |
| inhibitors | 3763 |
| intubation | 3759 |
| characterized | 3754 |
| cost | 3752 |
| antiviral | 3752 |
| continuous | 3743 |
| identification | 3733 |
| selected | 3733 |
| material | 3724 |
| infusion | 3723 |
| thrombosis | 3717 |
| protective | 3716 |
| done | 3712 |
| derived | 3706 |
| difficult | 3702 |
| pathogens | 3693 |
| potentially | 3691 |
| interventions | 3671 |
| none | 3642 |
| deficiency | 3635 |
| meta | 3635 |
| centers | 3632 |
| iii | 3619 |
| coronary | 3614 |
| essential | 3614 |
| asymptomatic | 3611 |
| global | 3602 |
| prophylaxis | 3599 |
| endothelial | 3595 |
| statistically | 3595 |
| performance | 3589 |
| ultrasound | 3587 |
| tnf | 3578 |
| expressed | 3572 |
| applied | 3568 |
| nasal | 3567 |
| relevant | 3557 |
| cerebral | 3555 |
| strains | 3550 |
| third | 3545 |
| now | 3542 |
| recorded | 3539 |
| medication | 3528 |
| social | 3527 |
| coagulation | 3523 |
| alone | 3516 |
| ventilator | 3515 |
| needs | 3506 |
| advanced | 3505 |
| prolonged | 3502 |
| gastrointestinal | 3498 |
| glucose | 3491 |
| real | 3483 |
| presenting | 3478 |
| die | 3473 |
| face | 3465 |
| carcinoma | 3463 |
| clinic | 3458 |
| hydroxychloroquine | 3446 |
| resulting | 3442 |
| ability | 3440 |
| metabolic | 3440 |
| approximately | 3439 |
| dl | 3432 |
| products | 3427 |
| calculated | 3423 |
| red | 3422 |
| moreover | 3421 |
| techniques | 3418 |
| mutation | 3414 |
| rt | 3404 |
| examined | 3401 |
| longer | 3400 |
| survey | 3392 |
| article | 3389 |
| mainly | 3385 |
| equipment | 3381 |
| set | 3379 |
| correlated | 3374 |
| tool | 3367 |
| complication | 3365 |
| catheter | 3363 |
| collection | 3357 |
| observational | 3352 |
| binding | 3350 |
| strategy | 3345 |
| delivery | 3342 |
| united | 3341 |
| noted | 3332 |
| uid | 3322 |
| conventional | 3317 |
| cross | 3317 |
| men | 3313 |
| inhibitor | 3307 |
| abnormal | 3289 |
| scan | 3284 |
| region | 3279 |
| resources | 3278 |
| capacity | 3274 |
| laparoscopic | 3268 |
| pathology | 3267 |
| hla | 3264 |
| application | 3261 |
| ifn | 3260 |
| subsequent | 3252 |
| importance | 3252 |
| become | 3246 |
| treat | 3242 |
| csf | 3241 |
| full | 3240 |
| cellular | 3233 |
| across | 3229 |
| visits | 3223 |
| proportion | 3213 |
| undergoing | 3212 |
| und | 3198 |
| particular | 3196 |
| specimens | 3187 |
| service | 3185 |
| pathogenesis | 3176 |
| late | 3176 |
| aged | 3144 |
| urinary | 3138 |
| antimicrobial | 3136 |
| shows | 3133 |
| developing | 3133 |
| relapse | 3132 |
| reactions | 3132 |
| sd | 3131 |
| increases | 3130 |
| prognostic | 3130 |
| march | 3123 |
| symptom | 3123 |
| recurrent | 3115 |
| workers | 3109 |
| medications | 3108 |
| young | 3107 |
| investigate | 3105 |
| estimated | 3099 |
| pathway | 3094 |
| consistent | 3093 |
| operative | 3085 |
| head | 3084 |
| temperature | 3082 |
| education | 3070 |
| sex | 3064 |
| guidance | 3060 |
| consent | 3053 |
| see | 3050 |
| example | 3049 |
| materials | 3044 |
| alternative | 3040 |
| epidemic | 3037 |
| american | 3033 |
| influence | 3030 |
| physician | 3021 |
| evs | 3020 |
| allogeneic | 3019 |
| title | 3015 |
| patterns | 3013 |
| problems | 3011 |
| regimen | 3011 |
| agent | 3010 |
| enzyme | 3002 |
| epithelial | 2997 |
| formation | 2996 |
| serious | 2988 |
| occurs | 2987 |
| suggests | 2985 |
| basis | 2979 |
| avoid | 2975 |
| placebo | 2974 |
| describe | 2970 |
| ms | 2969 |
| measurements | 2968 |
| hcv | 2960 |
| yet | 2959 |
| corticosteroids | 2957 |
| much | 2956 |
| vivo | 2956 |
| tube | 2956 |
| investigation | 2955 |
| telemedicine | 2955 |
| approved | 2947 |
| clear | 2946 |
| hemorrhage | 2945 |
| lymphocytes | 2936 |
| activated | 2935 |
| delayed | 2932 |
| pregnancy | 2932 |
| achieved | 2927 |
| seven | 2927 |
| making | 2925 |
| doc | 2924 |
| understanding | 2923 |
| spectrum | 2920 |
| cmv | 2916 |
| multi | 2911 |
| adequate | 2908 |
| optimal | 2902 |
| isolates | 2895 |
| rapidly | 2892 |
| resolution | 2892 |
| experienced | 2890 |
| sha | 2887 |
| crp | 2886 |
| reactive | 2883 |
| january | 2868 |
| terms | 2865 |
| source | 2864 |
| person | 2863 |
| stable | 2863 |
| proposed | 2862 |
| lymphocyte | 2862 |
| summary | 2849 |
| minutes | 2848 |
| around | 2848 |
| ae | 2838 |
| urine | 2832 |
| phenotype | 2831 |
| degree | 2826 |
| percentage | 2823 |
| personal | 2821 |
| tumour | 2819 |
| generally | 2815 |
| started | 2810 |
| others | 2809 |
| obesity | 2805 |
| radiation | 2804 |
| effectiveness | 2802 |
| excluded | 2799 |
| settings | 2799 |
| toxicity | 2798 |
| receive | 2794 |
| double | 2794 |
| bilateral | 2793 |
| malignant | 2791 |
| ecmo | 2789 |
| members | 2788 |
| finally | 2783 |
| matched | 2780 |
| resulted | 2780 |
| specificity | 2780 |
| unknown | 2778 |
| components | 2777 |
| image | 2775 |
| deaths | 2774 |
| european | 2770 |
| gastric | 2770 |
| protection | 2763 |
| make | 2762 |
| successful | 2756 |
| risks | 2754 |
| mr | 2750 |
| predictive | 2750 |
| lungs | 2749 |
| resection | 2747 |
| st | 2745 |
| expected | 2744 |
| providers | 2743 |
| provides | 2742 |
| enhanced | 2741 |
| consecutive | 2739 |
| implementation | 2737 |
| ng | 2735 |
| indicate | 2733 |
| perfusion | 2732 |
| relatively | 2726 |
| directly | 2725 |
| way | 2724 |
| beta | 2724 |
| vaccine | 2722 |
| platelets | 2721 |
| ventricular | 2717 |
| finding | 2712 |
| alveolar | 2711 |
| activities | 2710 |
| species | 2710 |
| infants | 2709 |
| survivors | 2707 |
| half | 2705 |
| suggesting | 2703 |
| proliferation | 2695 |
| event | 2693 |
| clinicians | 2690 |
| hbv | 2690 |
| pd | 2688 |
| lymphoma | 2684 |
| reducing | 2682 |
| affect | 2676 |
| ischemic | 2675 |
| ongoing | 2674 |
| lesion | 2670 |
| induction | 2670 |
| middle | 2665 |
| compare | 2660 |
| angiotensin | 2653 |
| protocols | 2653 |
| carried | 2652 |
| analysed | 2651 |
| rats | 2647 |
| cultures | 2642 |
| device | 2642 |
| interval | 2638 |
| partial | 2635 |
| injection | 2630 |
| plus | 2626 |
| position | 2625 |
| diffuse | 2618 |
| requires | 2617 |
| play | 2616 |
| allow | 2615 |
| hr | 2614 |
| animals | 2612 |
| enrolled | 2612 |
| technology | 2611 |
| rather | 2609 |
| already | 2607 |
| susceptibility | 2605 |
| bowel | 2605 |
| necrosis | 2601 |
| tissues | 2599 |
| variable | 2597 |
| final | 2592 |
| neutrophil | 2592 |
| inhibition | 2591 |
| symptomatic | 2590 |
| wall | 2589 |
| reference | 2589 |
| detect | 2585 |
| relative | 2584 |
| water | 2583 |
| autoimmune | 2583 |
| progressive | 2583 |
| disorder | 2579 |
| existing | 2579 |
| predict | 2579 |
| receptors | 2576 |
| numbers | 2574 |
| intestinal | 2574 |
| points | 2573 |
| sensitive | 2572 |
| place | 2568 |
| ca | 2553 |
| responsible | 2550 |
| along | 2544 |
| tocilizumab | 2541 |
| highest | 2538 |
| demonstrate | 2537 |
| mental | 2533 |
| led | 2532 |
| outpatient | 2528 |
| contribute | 2528 |
| perform | 2528 |
| immunity | 2525 |
| mers | 2523 |
| centre | 2522 |
| eight | 2520 |
| significance | 2518 |
| pneumoniae | 2510 |
| next | 2509 |
| conditioning | 2508 |
| communication | 2506 |
| consensus | 2504 |
| measure | 2503 |
| discharged | 2496 |
| surveillance | 2495 |
| allergic | 2491 |
| seems | 2485 |
| mmhg | 2484 |
| lymph | 2484 |
| context | 2483 |
| includes | 2483 |
| compliance | 2482 |
| males | 2481 |
| bmi | 2480 |
| quantitative | 2478 |
| consider | 2476 |
| refractory | 2475 |
| learning | 2471 |
| clearance | 2470 |
| appears | 2467 |
| populations | 2459 |
| differential | 2456 |
| counts | 2454 |
| sites | 2454 |
| remain | 2452 |
| nurses | 2448 |
| edema | 2447 |
| issues | 2444 |
| version | 2443 |
| organization | 2441 |
| environment | 2440 |
| sputum | 2433 |
| insulin | 2430 |
| accuracy | 2428 |
| injuries | 2427 |
| operation | 2421 |
| animal | 2418 |
| documented | 2418 |
| implications | 2416 |
| additionally | 2415 |
| recurrence | 2414 |
| selection | 2413 |
| chain | 2413 |
| challenges | 2411 |
| preliminary | 2405 |
| records | 2399 |
| oxygenation | 2397 |
| nerve | 2397 |
| persistent | 2396 |
| problem | 2392 |
| certain | 2390 |
| profile | 2388 |
| fact | 2387 |
| nk | 2385 |
| peak | 2385 |
| classification | 2383 |
| wide | 2380 |
| impaired | 2380 |
| designed | 2377 |
| containing | 2375 |
| sequencing | 2374 |
| thoracic | 2374 |
| step | 2372 |
| interferon | 2371 |
| aimed | 2366 |
| close | 2364 |
| challenge | 2362 |
| impairment | 2359 |
| ppe | 2358 |
| cr | 2355 |
| interstitial | 2353 |
| gender | 2352 |
| informed | 2351 |
| means | 2345 |
| completed | 2344 |
| cap | 2344 |
| together | 2338 |
| aims | 2336 |
| regions | 2335 |
| almost | 2333 |
| database | 2332 |
| focus | 2331 |
| macrophages | 2328 |
| replacement | 2328 |
| strong | 2326 |
| experimental | 2325 |
| remained | 2325 |
| aureus | 2325 |
| visit | 2323 |
| des | 2321 |
| white | 2320 |
| supported | 2320 |
| practices | 2316 |
| pro | 2315 |
| divided | 2314 |
| regional | 2313 |
| measurement | 2313 |
| uk | 2310 |
| larger | 2306 |
| diarrhea | 2303 |
| italy | 2301 |
| heparin | 2301 |
| burden | 2300 |
| los | 2300 |
| usa | 2300 |
| ph | 2298 |
| marker | 2294 |
| situation | 2293 |
| load | 2292 |
| initially | 2291 |
| devices | 2291 |
| forms | 2290 |
| april | 2290 |
| committee | 2288 |
| interleukin | 2284 |
| preprint | 2280 |
| class | 2279 |
| working | 2278 |
| occurrence | 2277 |
| arthritis | 2276 |
| past | 2275 |
| child | 2273 |
| biological | 2273 |
| pet | 2272 |
| take | 2262 |
| episodes | 2262 |
| linked | 2255 |
| lines | 2253 |
| hematopoietic | 2250 |
| thrombocytopenia | 2248 |
| females | 2244 |
| exposed | 2243 |
| alpha | 2242 |
| allows | 2242 |
| field | 2242 |
| institute | 2241 |
| providing | 2239 |
| interaction | 2237 |
| generation | 2237 |
| benefits | 2231 |
| epidemiological | 2225 |
| action | 2215 |
| gram | 2215 |
| transfer | 2212 |
| amount | 2210 |
| continued | 2209 |
| nature | 2207 |
| sequence | 2199 |
| nosocomial | 2199 |
| placed | 2198 |
| pathological | 2197 |
| though | 2195 |
| biomarkers | 2193 |
| tomography | 2190 |
| discussed | 2189 |
| assays | 2188 |
| cystic | 2186 |
| tuberculosis | 2185 |
| limitations | 2184 |
| nursing | 2182 |
| pathogen | 2179 |
| pleural | 2176 |
| leads | 2175 |
| far | 2175 |
| obstruction | 2172 |
| classified | 2172 |
| delay | 2171 |
| intensity | 2170 |
| treating | 2167 |
| creatinine | 2166 |
| taking | 2166 |
| produced | 2165 |
| leukemia | 2164 |
| pathways | 2162 |
| questionnaire | 2160 |
| ensure | 2156 |
| neutrophils | 2156 |
| worldwide | 2156 |
| widely | 2154 |
| el | 2154 |
| fold | 2154 |
| costs | 2154 |
| complement | 2153 |
| cftr | 2152 |
| os | 2151 |
| dimer | 2150 |
| causing | 2150 |
| concern | 2150 |
| regulation | 2147 |
| reporting | 2141 |
| ncov | 2139 |
| mask | 2136 |
| maximum | 2134 |
| rejection | 2132 |
| discussion | 2129 |
| urgent | 2122 |
| involving | 2119 |
| predicted | 2115 |
| institution | 2114 |
| questions | 2109 |
| hour | 2109 |
| immunosuppression | 2107 |
| organs | 2106 |
| immediately | 2095 |
| gas | 2093 |
| retrospectively | 2092 |
| exercise | 2091 |
| electronic | 2086 |
| food | 2084 |
| product | 2081 |
| operating | 2079 |
| typical | 2079 |
| adjusted | 2075 |
| obstructive | 2075 |
| reasons | 2072 |
| se | 2071 |
| dialysis | 2071 |
| immunoglobulin | 2066 |
| radiological | 2066 |
| stimulation | 2066 |
| chinese | 2064 |
| epidemiology | 2062 |
| outside | 2062 |
| approaches | 2062 |
| subsequently | 2061 |
| computed | 2060 |
| processes | 2056 |
| except | 2056 |
| multivariate | 2055 |
| december | 2053 |
| ten | 2052 |
| light | 2052 |
| referred | 2050 |
| initiation | 2047 |
| minimal | 2046 |
| apoptosis | 2041 |
| inclusion | 2040 |
| natural | 2040 |
| internal | 2039 |
| aki | 2036 |
| oncology | 2035 |
| diabetic | 2034 |
| entry | 2033 |
| choice | 2033 |
| anemia | 2031 |
| content | 2030 |
| signal | 2030 |
| attention | 2028 |
| dental | 2025 |
| panel | 2025 |
| iron | 2025 |
| iqr | 2022 |
| copyright | 2022 |
| cognitive | 2021 |
| software | 2018 |
| structure | 2016 |
| ray | 2016 |
| availability | 2015 |
| signifi | 2014 |
| etiology | 2014 |
| infarction | 2013 |
| successfully | 2012 |
| simple | 2011 |
| targeted | 2010 |
| remaining | 2010 |
| immunodeficiency | 2009 |
| represent | 2009 |
| mixed | 2007 |
| interactions | 2005 |
| multicenter | 2005 |
| little | 2001 |
| depression | 1999 |
| smoking | 1993 |
| solution | 1992 |
| anesthesia | 1991 |
| anticoagulation | 1990 |
| extensive | 1989 |
| special | 1987 |
| throughout | 1986 |
| unique | 1981 |
| personnel | 1979 |
| fatal | 1978 |
| nine | 1971 |
| predictors | 1970 |
| demographic | 1967 |
| emerging | 1965 |
| allowed | 1961 |
| origin | 1959 |
| accurate | 1959 |
| possibility | 1954 |
| extent | 1948 |
| account | 1948 |
| limit | 1947 |
| appear | 1947 |
| rehabilitation | 1947 |
| sleep | 1944 |
| option | 1944 |
| rbc | 1942 |
| humans | 1941 |
| network | 1941 |
| induce | 1941 |
| malignancy | 1936 |
| density | 1934 |
| ev | 1933 |
| steroids | 1933 |
| typically | 1932 |
| fractures | 1932 |
| sedation | 1931 |
| remdesivir | 1930 |
| traumatic | 1928 |
| circulating | 1928 |
| chloroquine | 1928 |
| solid | 1922 |
| indications | 1921 |
| remission | 1919 |
| storm | 1919 |
| arrest | 1917 |
| recommend | 1916 |
| ventilated | 1916 |
| immediate | 1916 |
| comparing | 1914 |
| resuscitation | 1914 |
| modified | 1913 |
| preoperative | 1910 |
| specifically | 1906 |
| myocarditis | 1905 |
| aspects | 1904 |
| elective | 1902 |
| repeated | 1899 |
| dr | 1898 |
| antigens | 1894 |
| maintain | 1894 |
| towards | 1893 |
| continue | 1892 |
| considering | 1891 |
| depending | 1890 |
| albumin | 1890 |
| neck | 1889 |
| space | 1889 |
| component | 1885 |
| molecules | 1885 |
| twenty | 1884 |
| media | 1881 |
| adherence | 1879 |
| ward | 1877 |
| logistic | 1877 |
| start | 1877 |
| igm | 1876 |
| monitored | 1873 |
| donation | 1872 |
| malignancies | 1868 |
| ischemia | 1867 |
| observation | 1867 |
| vein | 1866 |
| always | 1864 |
| proven | 1861 |
| implemented | 1860 |
| facilities | 1855 |
| probably | 1854 |
| spontaneous | 1853 |
| variety | 1853 |
| beneficial | 1853 |
| recognized | 1851 |
| location | 1851 |
| deep | 1850 |
| cirrhosis | 1846 |
| fat | 1845 |
| video | 1844 |
| autologous | 1843 |
| differentiation | 1842 |
| extracellular | 1839 |
| guide | 1839 |
| repair | 1839 |
| azithromycin | 1837 |
| improving | 1833 |
| signaling | 1830 |
| thrombotic | 1829 |
| pt | 1828 |
| vessels | 1824 |
| regimens | 1823 |
| mrsa | 1821 |
| understand | 1820 |
| added | 1816 |
| comparable | 1812 |
| metabolism | 1807 |
| triage | 1806 |
| lactate | 1805 |
| steroid | 1803 |
| note | 1801 |
| allergy | 1799 |
| congenital | 1799 |
| surgeons | 1796 |
| altered | 1796 |
| replication | 1793 |
| paper | 1792 |
| institutional | 1790 |
| mouse | 1790 |
| author | 1790 |
| vaccination | 1789 |
| confirm | 1788 |
| mrna | 1787 |
| sct | 1786 |
| goal | 1781 |
| regulatory | 1778 |
| infl | 1776 |
| younger | 1775 |
| hemodynamic | 1775 |
| concerns | 1774 |
| initiated | 1773 |
| plan | 1771 |
| delirium | 1770 |
| worse | 1770 |
| aspiration | 1769 |
| professionals | 1768 |
| variation | 1764 |
| manuscript | 1764 |
| managed | 1764 |
| atypical | 1763 |
| comprehensive | 1763 |
| strongly | 1762 |
| removal | 1762 |
| contamination | 1760 |
| colon | 1760 |
| breathing | 1759 |
| fully | 1759 |
| indicating | 1758 |
| maintenance | 1757 |
| ivig | 1756 |
| biopsies | 1755 |
| fl | 1755 |
| validation | 1755 |
| decisions | 1754 |
| lps | 1752 |
| medium | 1751 |
| pg | 1750 |
| monoclonal | 1748 |
| unclear | 1748 |
| variants | 1745 |
| resource | 1745 |
| scans | 1744 |
| showing | 1742 |
| complicated | 1737 |
| ra | 1736 |
| regular | 1734 |
| recognition | 1734 |
| crucial | 1733 |
| sodium | 1733 |
| tools | 1732 |
| fio | 1731 |
| relation | 1731 |
| section | 1730 |
| similarly | 1730 |
| inpatient | 1729 |
| histological | 1724 |
| functions | 1721 |
| pregnant | 1721 |
| strain | 1719 |
| dyspnea | 1718 |
| mostly | 1717 |
| staining | 1716 |
| properties | 1715 |
| earlier | 1714 |
| unrelated | 1713 |
| germany | 1713 |
| precautions | 1710 |
| benign | 1707 |
| immunosuppressive | 1706 |
| metastatic | 1704 |
| abstract | 1703 |
| scientific | 1702 |
| con | 1702 |
| recovered | 1699 |
| stages | 1699 |
| er | 1698 |
| options | 1696 |
| ritonavir | 1695 |
| ige | 1695 |
| reason | 1694 |
| endoscopic | 1694 |
| hypothesis | 1691 |
| generated | 1691 |
| requirements | 1690 |
| basic | 1689 |
| vitamin | 1688 |
| registry | 1688 |
| project | 1687 |
| fracture | 1681 |
| anxiety | 1677 |
| colorectal | 1676 |
| innate | 1675 |
| broad | 1674 |
| twice | 1673 |
| view | 1671 |
| distal | 1670 |
| algorithm | 1666 |
| medrxiv | 1666 |
| vital | 1665 |
| hypoxia | 1665 |
| secretion | 1663 |
| nodes | 1662 |
| preventing | 1661 |
| lopinavir | 1660 |
| transport | 1655 |
| monocytes | 1654 |
| prone | 1653 |
| online | 1652 |
| corresponding | 1651 |
| fungal | 1650 |
| neurologic | 1650 |
| randomised | 1649 |
| search | 1649 |
| organisms | 1648 |
| wound | 1647 |
| achieve | 1646 |
| great | 1646 |
| radiology | 1646 |
| genotype | 1640 |
| vap | 1640 |
| uptake | 1640 |
| city | 1640 |
| represents | 1636 |
| crisis | 1634 |
| monitor | 1634 |
| definition | 1632 |
| ethics | 1632 |
| pathogenic | 1631 |
| living | 1630 |
| produce | 1629 |
| bed | 1629 |
| susceptible | 1629 |
| prediction | 1629 |
| disclosure | 1627 |
| prostate | 1625 |
| million | 1625 |
| polymerase | 1624 |
| allo | 1624 |
| persons | 1623 |
| environmental | 1623 |
| elisa | 1622 |
| tertiary | 1622 |
| promising | 1620 |
| met | 1620 |
| pancreatic | 1619 |
| sufficient | 1619 |
| intra | 1617 |
| feasible | 1616 |
| percent | 1615 |
| admissions | 1613 |
| cycle | 1613 |
| primarily | 1612 |
| possibly | 1612 |
| find | 1611 |
| telehealth | 1611 |
| joint | 1611 |
| families | 1610 |
| curve | 1610 |
| dynamic | 1609 |
| etc | 1608 |
| conflict | 1608 |
| hct | 1606 |
| detailed | 1606 |
| preparation | 1606 |
| fatigue | 1605 |
| located | 1605 |
| base | 1602 |
| bladder | 1600 |
| nutrition | 1600 |
| pe | 1598 |
| differ | 1596 |
| convalescent | 1596 |
| transplanted | 1595 |
| indication | 1594 |
| guideline | 1593 |
| reserved | 1591 |
| mmol | 1590 |
| rights | 1585 |
| alterations | 1585 |
| virtual | 1585 |
| reliable | 1584 |
| angiography | 1583 |
| anterior | 1583 |
| threatening | 1581 |
| severely | 1581 |
| hygiene | 1580 |
| license | 1579 |
| success | 1575 |
| mellitus | 1574 |
| obtain | 1574 |
| consequences | 1574 |
| extended | 1571 |
| traditional | 1570 |
| independently | 1569 |
| transferred | 1569 |
| coagulopathy | 1568 |
| cns | 1568 |
| marked | 1567 |
| beyond | 1567 |
| saturation | 1566 |
| tumours | 1565 |
| nervous | 1565 |
| standardized | 1564 |
| examinations | 1564 |
| node | 1564 |
| consultation | 1563 |
| validated | 1563 |
| exacerbations | 1562 |
| country | 1561 |
| aml | 1559 |
| thyroid | 1558 |
| mit | 1557 |
| interpretation | 1557 |
| just | 1557 |
| distinct | 1556 |
| coronaviruses | 1555 |
| tbi | 1554 |
| characteristic | 1554 |
| spinal | 1553 |
| placement | 1549 |
| residual | 1549 |
| thought | 1549 |
| linear | 1549 |
| eye | 1546 |
| transfusions | 1546 |
| seizures | 1545 |
| pao | 1545 |
| performing | 1544 |
| fraction | 1544 |
| focal | 1540 |
| trend | 1538 |
| arm | 1537 |
| variability | 1537 |
| elevation | 1536 |
| intracranial | 1534 |
| idiopathic | 1534 |
| kinase | 1534 |
| starting | 1532 |
| act | 1532 |
| microscopy | 1531 |
| diameter | 1530 |
| recipient | 1530 |
| hemoglobin | 1529 |
| von | 1529 |
| obese | 1528 |
| energy | 1528 |
| birth | 1527 |
| aeruginosa | 1526 |
| sequences | 1525 |
| consisted | 1525 |
| circulation | 1525 |
| confidence | 1520 |
| external | 1520 |
| protected | 1520 |
| establish | 1519 |
| calcium | 1519 |
| ethical | 1517 |
| probability | 1516 |
| storage | 1514 |
| called | 1512 |
| failed | 1512 |
| worsening | 1510 |
| focused | 1507 |
| org | 1507 |
| eine | 1506 |
| vomiting | 1506 |
| evolution | 1506 |
| balance | 1505 |
| interestingly | 1505 |
| pa | 1505 |
| saline | 1503 |
| helpful | 1502 |
| substantial | 1501 |
| correct | 1498 |
| hemorrhagic | 1497 |
| extracorporeal | 1497 |
| reduces | 1497 |
| targeting | 1497 |
| diagnoses | 1496 |
| evaluating | 1496 |
| vessel | 1495 |
| breath | 1494 |
| descriptive | 1494 |
| aortic | 1492 |
| nurse | 1490 |
| clearly | 1490 |
| posterior | 1489 |
| transcription | 1487 |
| consideration | 1486 |
| bronchial | 1486 |
| multidisciplinary | 1485 |
| display | 1484 |
| whose | 1482 |
| peptide | 1481 |
| concerning | 1480 |
| embolism | 1479 |
| bal | 1479 |
| assessing | 1478 |
| tb | 1478 |
| technical | 1478 |
| rooms | 1477 |
| supply | 1474 |
| genome | 1473 |
| cumulative | 1472 |
| drainage | 1472 |
| programs | 1472 |
| remote | 1471 |
| lipid | 1471 |
| les | 1470 |
| expert | 1470 |
| occurring | 1469 |
| label | 1469 |
| completely | 1467 |
| alcohol | 1467 |
| immunocompromised | 1467 |
| regard | 1467 |
| subject | 1466 |
| recruitment | 1466 |
| back | 1465 |
| prospectively | 1465 |
| nuclear | 1464 |
| removed | 1464 |
| minimize | 1464 |
| address | 1462 |
| childhood | 1462 |
| superior | 1461 |
| respect | 1461 |
| particles | 1460 |
| prophylactic | 1459 |
| staphylococcus | 1459 |
| east | 1458 |
| peep | 1458 |
| syndromes | 1458 |
| fev | 1457 |
| variant | 1455 |
| cancers | 1455 |
| accepted | 1453 |
| progress | 1446 |
| minimum | 1446 |
| question | 1444 |
| became | 1444 |
| concomitant | 1444 |
| exacerbation | 1443 |
| france | 1439 |
| examine | 1439 |
| digital | 1438 |
| targets | 1437 |
| investigations | 1436 |
| coli | 1435 |
| ranging | 1434 |
| reverse | 1431 |
| neonatal | 1431 |
| cytometry | 1430 |
| bias | 1430 |
| cc | 1429 |
| agreement | 1426 |
| psychological | 1425 |
| output | 1425 |
| cdc | 1424 |
| pulse | 1423 |
| proper | 1421 |
| changed | 1420 |
| june | 1420 |
| appearance | 1419 |
| defects | 1419 |
| aggressive | 1418 |
| supportive | 1418 |
| synthesis | 1417 |
| le | 1416 |
| mir | 1416 |
| challenging | 1413 |
| simulation | 1413 |
| headache | 1413 |
| es | 1412 |
| efforts | 1411 |
| aerosol | 1410 |
| identifying | 1408 |
| japan | 1403 |
| maintained | 1403 |
| periods | 1403 |
| sclerosis | 1402 |
| enhancement | 1400 |
| atrial | 1399 |
| rarely | 1399 |
| school | 1398 |
| swab | 1397 |
| facilitate | 1397 |
| airways | 1397 |
| toxic | 1396 |
| encephalopathy | 1394 |
| vte | 1394 |
| deterioration | 1393 |
| hence | 1392 |
| visual | 1390 |
| planning | 1390 |
| corticosteroid | 1389 |
| incubation | 1388 |
| prescribed | 1387 |
| processing | 1386 |
| disseminated | 1384 |
| western | 1383 |
| neutropenia | 1382 |
| del | 1381 |
| absolute | 1374 |
| statement | 1374 |
| february | 1373 |
| paediatric | 1372 |
| approval | 1372 |
| standards | 1371 |
| niv | 1369 |
| easily | 1368 |
| engraftment | 1367 |
| policy | 1367 |
| cutaneous | 1366 |
| exact | 1365 |
| physiological | 1364 |
| structural | 1362 |
| true | 1362 |
| lateral | 1362 |
| pilot | 1361 |
| efficient | 1358 |
| icus | 1358 |
| rest | 1358 |
| ranged | 1358 |
| promote | 1356 |
| exchange | 1356 |
| intake | 1355 |
| europe | 1354 |
| numerous | 1354 |
| needle | 1352 |
| massive | 1352 |
| predicting | 1350 |
| structures | 1350 |
| psychiatric | 1349 |
| dosing | 1347 |
| hb | 1347 |
| decline | 1347 |
| predictor | 1346 |
| consumption | 1346 |
| defect | 1345 |
| infiltration | 1345 |
| https | 1344 |
| diet | 1344 |
| protect | 1344 |
| adhesion | 1343 |
| acquisition | 1341 |
| efficiency | 1340 |
| wt | 1339 |
| masks | 1337 |
| cut | 1336 |
| rheumatoid | 1336 |
| proximal | 1335 |
| ferritin | 1335 |
| tolerance | 1335 |
| reached | 1334 |
| magnetic | 1333 |
| automated | 1332 |
| odds | 1331 |
| affecting | 1331 |
| radiographic | 1330 |
| im | 1329 |
| macrophage | 1329 |
| ad | 1327 |
| dedicated | 1326 |
| extracted | 1326 |
| dm | 1325 |
| utilization | 1325 |
| colleagues | 1324 |
| issue | 1324 |
| doctors | 1323 |
| follows | 1323 |
| bei | 1322 |
| observations | 1322 |
| fetal | 1321 |
| professional | 1320 |
| man | 1320 |
| nutritional | 1319 |
| blind | 1317 |
| hypotension | 1317 |
| pc | 1317 |
| core | 1316 |
| nevertheless | 1316 |
| shorter | 1315 |
| nd | 1315 |
| olfactory | 1314 |
| indeed | 1314 |
| prepared | 1314 |
| gamma | 1314 |
| bp | 1313 |
| eeg | 1313 |
| throat | 1312 |
| cervical | 1311 |
| gi | 1311 |
| otherwise | 1311 |
| hcc | 1310 |
| ribavirin | 1310 |
| parents | 1310 |
| sp | 1308 |
| created | 1308 |
| screened | 1306 |
| appeared | 1306 |
| facility | 1306 |
| portal | 1305 |
| fda | 1302 |
| estimate | 1298 |
| arteries | 1298 |
| fluids | 1298 |
| motor | 1298 |
| sign | 1297 |
| ab | 1294 |
| travel | 1293 |
| return | 1292 |
| extremely | 1289 |
| gm | 1288 |
| specimen | 1286 |
| inhibit | 1286 |
| latter | 1285 |
| outbreaks | 1284 |
| prescription | 1284 |
| record | 1283 |
| eosinophils | 1283 |
| newly | 1281 |
| declare | 1280 |
| beginning | 1280 |
| explain | 1280 |
| minute | 1279 |
| intracellular | 1278 |
| improves | 1278 |
| platform | 1278 |
| false | 1278 |
| maternal | 1274 |
| sustained | 1274 |
| converting | 1274 |
| directed | 1273 |
| preferred | 1273 |
| eligible | 1270 |
| glass | 1267 |
| ich | 1267 |
| separate | 1267 |
| memory | 1267 |
| autopsy | 1266 |
| entire | 1265 |
| selective | 1264 |
| barrier | 1263 |
| know | 1262 |
| rise | 1262 |
| categories | 1261 |
| metastases | 1260 |
| give | 1260 |
| near | 1260 |
| inhaled | 1259 |
| timing | 1259 |
| manage | 1259 |
| comorbidity | 1259 |
| guided | 1258 |
| immunological | 1258 |
| recombinant | 1258 |
| bypass | 1257 |
| perioperative | 1256 |
| referral | 1254 |
| practical | 1254 |
| feature | 1253 |
| usual | 1253 |
| routinely | 1253 |
| students | 1251 |
| cluster | 1250 |
| exclusion | 1250 |
| undergo | 1248 |
| consolidation | 1247 |
| iga | 1246 |
| mucosa | 1246 |
| increasingly | 1246 |
| college | 1245 |
| ns | 1242 |
| sampling | 1242 |
| effectively | 1242 |
| articles | 1239 |
| fast | 1237 |
| trained | 1237 |
| pneumothorax | 1236 |
| domain | 1236 |
| introduced | 1236 |
| tlr | 1235 |
| ebv | 1234 |
| pathophysiology | 1233 |
| intubated | 1232 |
| never | 1231 |
| indicates | 1231 |
| departments | 1231 |
| systolic | 1231 |
| gloves | 1231 |
| radiotherapy | 1230 |
| lavage | 1230 |
| recommendation | 1229 |
| ground | 1228 |
| situations | 1227 |
| residents | 1227 |
| threshold | 1226 |
| excellent | 1225 |
| recruited | 1224 |
| hcq | 1224 |
| suffering | 1224 |
| biochemical | 1223 |
| stimulated | 1222 |
| mode | 1221 |
| dosage | 1221 |
| rsv | 1220 |
| considerations | 1219 |
| thromboembolism | 1217 |
| distance | 1216 |
| written | 1216 |
| reach | 1215 |
| asked | 1215 |
| testicular | 1214 |
| rhd | 1213 |
| kit | 1213 |
| producing | 1213 |
| www | 1213 |
| diffusion | 1211 |
| provider | 1211 |
| suspicion | 1209 |
| sources | 1209 |
| ebola | 1209 |
| strength | 1208 |
| plays | 1207 |
| centres | 1206 |
| power | 1206 |
| noninvasive | 1205 |
| predominantly | 1205 |
| analyze | 1205 |
| closed | 1204 |
| apache | 1204 |
| sometimes | 1204 |
| manner | 1204 |
| define | 1202 |
| delivered | 1202 |
| clinics | 1202 |
| economic | 1201 |
| update | 1201 |
| insertion | 1201 |
| transient | 1200 |
| allowing | 1200 |
| registered | 1200 |
| matter | 1199 |
| volunteers | 1198 |
| presents | 1198 |
| financial | 1196 |
| hernia | 1195 |
| soft | 1195 |
| employed | 1193 |
| accumulation | 1193 |
| stored | 1192 |
| nucleic | 1192 |
| steps | 1191 |
| details | 1191 |
| bedside | 1191 |
| ecg | 1190 |
| closely | 1189 |
| beds | 1187 |
| associations | 1187 |
| esophageal | 1186 |
| determination | 1185 |
| block | 1184 |
| weaning | 1183 |
| valve | 1183 |
| enzymes | 1183 |
| intervals | 1183 |
| myeloid | 1183 |
| spain | 1182 |
| sub | 1182 |
| teams | 1181 |
| nasopharyngeal | 1180 |
| principles | 1180 |
| experiments | 1180 |
| surfaces | 1179 |
| seem | 1179 |
| suitable | 1179 |
| volumes | 1178 |
| relationships | 1178 |
| stenosis | 1177 |
| fibrinogen | 1177 |
| un | 1176 |
| released | 1176 |
| vaccines | 1176 |
| mucosal | 1175 |
| expansion | 1174 |
| inpatients | 1173 |
| percutaneous | 1173 |
| pr | 1172 |
| enhance | 1171 |
| nearly | 1170 |
| satisfaction | 1170 |
| rectal | 1170 |
| frailty | 1169 |
| screen | 1169 |
| catheters | 1169 |
| excessive | 1168 |
| alt | 1168 |
| cohorts | 1168 |
| endotracheal | 1167 |
| hypoxemia | 1165 |
| colitis | 1164 |
| utility | 1164 |
| subgroup | 1164 |
| original | 1164 |
| institutions | 1163 |
| sofa | 1163 |
| neither | 1163 |
| effusion | 1162 |
| basal | 1162 |
| feasibility | 1161 |
| tolerated | 1161 |
| cant | 1161 |
| hands | 1161 |
| managing | 1160 |
| slightly | 1159 |
| enough | 1159 |
| gut | 1157 |
| neuropathy | 1157 |
| rat | 1155 |
| rituximab | 1155 |
| lymphopenia | 1155 |
| rr | 1154 |
| instead | 1153 |
| cultured | 1153 |
| profiles | 1152 |
| peer | 1151 |
| wards | 1149 |
| nausea | 1149 |
| accompanied | 1149 |
| transfused | 1147 |
| intravascular | 1147 |
| affects | 1147 |
| acids | 1147 |
| involves | 1147 |
| infiltrates | 1145 |
| soluble | 1144 |
| july | 1143 |
| poorly | 1143 |
| sections | 1142 |
| era | 1141 |
| auc | 1141 |
| qualitative | 1140 |
| tidal | 1140 |
| offer | 1139 |
| funding | 1139 |
| invasion | 1138 |
| york | 1138 |
| agvhd | 1138 |
| thereby | 1137 |
| lupus | 1137 |
| assisted | 1135 |
| minor | 1135 |
| measuring | 1134 |
| route | 1134 |
| oxidative | 1134 |
| educational | 1133 |
| contain | 1133 |
| mentioned | 1132 |
| reactivation | 1132 |
| potent | 1131 |
| technologies | 1131 |
| feeding | 1131 |
| bile | 1131 |
| repeat | 1131 |
| applications | 1130 |
| mic | 1129 |
| operations | 1128 |
| disability | 1128 |
| epithelium | 1128 |
| suppression | 1127 |
| list | 1127 |
| pi | 1126 |
| immunotherapy | 1125 |
| regardless | 1123 |
| febrile | 1123 |
| category | 1122 |
| awareness | 1122 |
| thirty | 1121 |
| modalities | 1120 |
| prevalent | 1119 |
| aids | 1119 |
| weighted | 1119 |
| ratios | 1119 |
| yield | 1119 |
| task | 1119 |
| protease | 1118 |
| fixed | 1118 |
| weekly | 1117 |
| metastasis | 1117 |
| endoscopy | 1116 |
| discuss | 1115 |
| easy | 1114 |
| ibd | 1114 |
| tm | 1113 |
| subset | 1113 |
| rbcs | 1111 |
| concept | 1111 |
| log | 1107 |
| largely | 1106 |
| temporal | 1105 |
| shift | 1104 |
| decreasing | 1103 |
| submitted | 1103 |
| peritoneal | 1103 |
| toward | 1102 |
| assigned | 1102 |
| board | 1101 |
| sectional | 1100 |
| cox | 1099 |
| south | 1098 |
| likelihood | 1097 |
| iu | 1097 |
| phenotypes | 1097 |
| waiting | 1096 |
| vesicles | 1095 |
| md | 1095 |
| identical | 1095 |
| allele | 1095 |
| intermediate | 1093 |
| weak | 1093 |
| solutions | 1092 |
| pelvic | 1092 |
| absent | 1092 |
| growing | 1090 |
| cyclophosphamide | 1090 |
| characterization | 1089 |
| nf | 1089 |
| utilized | 1088 |
| telephone | 1087 |
| cold | 1087 |
| palliative | 1087 |
| hd | 1086 |
| pathologic | 1086 |
| respond | 1085 |
| depends | 1085 |
| expiratory | 1084 |
| reflect | 1084 |
| correlate | 1083 |
| stability | 1083 |
| italian | 1082 |
| ar | 1081 |
| lobe | 1081 |
| demand | 1081 |
| planned | 1080 |
| encephalitis | 1080 |
| longitudinal | 1080 |
| resonance | 1079 |
| academic | 1078 |
| chi | 1076 |
| sent | 1076 |
| preventive | 1075 |
| science | 1075 |
| subcutaneous | 1074 |
| raised | 1073 |
| experiences | 1073 |
| weakness | 1072 |
| uncommon | 1070 |
| dexamethasone | 1070 |
| skills | 1069 |
| assist | 1069 |
| intraoperative | 1068 |
| terminal | 1067 |
| woman | 1066 |
| matrix | 1065 |
| amino | 1065 |
| univariate | 1065 |
| accordance | 1064 |
| occlusion | 1064 |
| barriers | 1062 |
| contributed | 1062 |
| integrated | 1060 |
| probable | 1060 |
| spleen | 1059 |
| serve | 1059 |
| vancomycin | 1059 |
| cavity | 1059 |
| exist | 1057 |
| map | 1057 |
| ic | 1056 |
| publication | 1054 |
| commercial | 1053 |
| migration | 1053 |
| abdomen | 1052 |
| rash | 1052 |
| pct | 1052 |
| errors | 1051 |
| hrs | 1050 |
| apparent | 1050 |
| tracheostomy | 1050 |
| radiologists | 1050 |
| pharmacy | 1049 |
| comparative | 1048 |
| biomarker | 1047 |
| perspective | 1047 |
| meet | 1047 |
| teaching | 1047 |
| decreases | 1047 |
| rd | 1046 |
| granted | 1045 |
| valuable | 1044 |
| secretions | 1044 |
| adenovirus | 1043 |
| icp | 1041 |
| widespread | 1041 |
| anticoagulant | 1041 |
| supplementary | 1040 |
| tubular | 1040 |
| filter | 1039 |
| live | 1039 |
| determining | 1039 |
| leukocyte | 1038 |
| interventional | 1038 |
| mediators | 1037 |
| avoided | 1037 |
| swabs | 1037 |
| distancing | 1036 |
| eg | 1036 |
| troponin | 1035 |
| induces | 1034 |
| cytotoxic | 1034 |
| effort | 1033 |
| nm | 1033 |
| streptococcus | 1033 |
| limb | 1031 |
| careful | 1031 |
| fusion | 1030 |
| cp | 1029 |
| maintaining | 1028 |
| lv | 1027 |
| usage | 1026 |
| dry | 1022 |
| explained | 1022 |
| meningitis | 1021 |
| molecule | 1021 |
| mv | 1019 |
| insufficiency | 1019 |
| gcs | 1018 |
| timely | 1017 |
| regulated | 1016 |
| manifestation | 1015 |
| pseudomonas | 1014 |
| varied | 1014 |
| conversion | 1014 |
| distributed | 1014 |
| blockade | 1014 |
| surgeries | 1013 |
| reconstruction | 1013 |
| depletion | 1013 |
| machine | 1012 |
| fewer | 1011 |
| transmitted | 1011 |
| femoral | 1011 |
| sle | 1010 |
| spine | 1008 |
| atg | 1008 |
| shared | 1008 |
| mechanically | 1008 |
| considerable | 1007 |
| dynamics | 1007 |
| surgeon | 1006 |
| mobile | 1006 |
| soon | 1006 |
| scoring | 1006 |
| fibrillation | 1006 |
| manual | 1006 |
| demographics | 1005 |
| laboratories | 1005 |
| sah | 1005 |
| bronchoscopy | 1004 |
| reasonable | 1004 |
| vary | 1002 |
| smaller | 1002 |
| declared | 1002 |
| supporting | 999 |
| oxide | 999 |
| amplification | 999 |
| favorable | 998 |
| markedly | 998 |
| thickness | 998 |
| mobilization | 998 |
| exam | 996 |
| indirect | 996 |
| bm | 996 |
| capillary | 995 |
| attributed | 995 |
| heterogeneity | 995 |
| tracheal | 995 |
| reactivity | 994 |
| myeloma | 994 |
| spike | 993 |
| gain | 993 |
| aid | 992 |
| hypothesized | 992 |
| sera | 992 |
| requirement | 991 |
| restricted | 991 |
| kidneys | 991 |
| limiting | 990 |
| consists | 990 |
| random | 990 |
| modality | 989 |
| abscess | 989 |
| explore | 988 |
| hematologic | 987 |
| investigators | 987 |
| suffered | 986 |
| immunohistochemical | 985 |
| episode | 985 |
| hematological | 985 |
| spp | 984 |
| advantages | 984 |
| equal | 984 |
| meeting | 984 |
| changing | 983 |
| extubation | 982 |
| prominent | 980 |
| insufficient | 980 |